Wednesday, April 16, 2025
Home Tags APHEX

Tag: APHEX

Superbug News - CoronaVirus Watch List

Aphex BioCleanse (SNST) Making Serious Headlines.

Editor / Curator -
Aphex Biocleanse Systems
Superbug News - CoronaVirus Watch List

Aphex BioCleanse Further Expands Distribution Channels.

Editor / Curator -
Dermaphex
Superbug News - CoronaVirus Watch List

Aphex BioCleanse System’s (SNST) Significant Hand Sanitizer Purchase Order.

Editor / Curator -
Biotech News

Make Hay While the Sun Shines. Up 6,400%.

Editor / Curator -
Aphex
CoronaVirus

Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement...

Editor / Curator -
Superbug News - CoronaVirus Watch List

Shark Tanks’ Kevin Harrington Gets Into Sanitizer Business.

Editor / Curator -
Biotech News

Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Editor / Curator -
Aphex BioCleanse
Biotech News

Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Photos: Aphex BioCleanse Systems.

Editor / Curator -
APHX, APHEX
Biotech News

Aphex BioCleanse Systems Inc, Expands Sanitizer Production at its New Manufacturing...

Editor / Curator -
12Page 1 of 2

Latest article

GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

2025 Watch List Editor / Curator -
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator -
LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...

Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!

2025 Watch List Editor / Curator -
This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.